PharmaCielo Ltd. (TSXV:PCLO) announced it entered into an implementation agreement with Creso Pharma Ltd. (ASX:CPH) to acquire all of Creso’s issued and outstanding shares and listed options.
The deal is for approximately A$122 million (about $85.2 million USD). PharmaCielo will pay 63 cents for each Creso share. Both PharmaCielo and Creso’s board of directors have unanimously approved the deal.
Need more cannabis news? Check out all of our coverage here.
Why It Matters
The acquisition is expected to give PharmaCielo …